Skip to content
ABOUT
AUTHOR GUIDELINES
AUTHORS/EDITORS
SUBSCRIPTIONS
CONTACT US
MY ACCOUNT
Facebook
X
LinkedIn
Instagram
Search
×
HOME
PSYCH. BULLETIN
LATEST ISSUE
BLACK BOOK OF DOSING & MONITORING
RATING SCALES
LICENSING INFORMATION
RESOURCES
PSYCHOTROPICS A-Z
PSYCHOPHARMACOLOGY 101
NEWS
Home
C. Lindsay DeVane, PharmD: An Explanation of the Second-Dose Effect in Pharmacokinetics and Its Meaning for Clinical Psychopharmacology
C. Lindsay DeVane, PharmD: An Explanation of the Second-Dose Effect in Pharmacokinetics and Its Meaning for Clinical Psychopharmacology
$
30.00
C. Lindsay DeVane, PharmD: An Explanation of the Second-Dose Effect in Pharmacokinetics and Its Meaning for Clinical Psychopharmacology quantity
Add to cart
Want a discount? Become a member by purchasing
Psychopharmacology Bulletin Subscription - Individual
!
Categories:
Psychopharmacology Bulletin
,
VOL 35 No. 1 Articles
Tags:
c-lindsay-devane
,
dosage-regimen-design
,
heidi-l-liston
,
medworks-media
,
pharmacokinetics
,
psychopharmacology
,
psychopharmacology-bulletin
,
second-dose-effect
Description
Description
C. Lindsay DeVane, PharmD
DRUG INTERACTIONS
An Explanation of the Second-Dose Effect in Pharmacokinetics and Its Meaning for Clinical Psychopharmacology
C. Lindsay DeVane, PharmD, and Heidi L. Liston, PharmD
Related products
Quetiapine XR Negative Clinical Trials Report by Gang Wang
$
30.00
Add to cart
Details
Antipsychotics Case Study by Yuan-Hwa Chou
$
30.00
Add to cart
Details
Quetiapine XR Randomized, Double-Blind Study by Arifulla Khan
$
30.00
Add to cart
Details
Roland Kuhn-100th Birthday of an Innovator of Clinical Psychopharmacology
$
30.00
Add to cart
Details
Page load link
Go to Top